Nishan Garabedian Christopher - Net Worth and Insider Trading
Nishan Garabedian Christopher Net Worth
The estimated net worth of Nishan Garabedian Christopher is at least $4 Million dollars as of 2024-11-10. Nishan Garabedian Christopher is the President and CEO of Sarepta Therapeutics Inc and owns about 29,552 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $4 Million. Details can be seen in Nishan Garabedian Christopher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nishan Garabedian Christopher has not made any transactions after 2015-02-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nishan Garabedian Christopher
Nishan Garabedian Christopher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nishan Garabedian Christopher owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of Nishan Garabedian Christopher’s form 4 insider trades.
Insider Ownership Summary of Nishan Garabedian Christopher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2015-02-27 | director |
Nishan Garabedian Christopher Latest Holdings Summary
Nishan Garabedian Christopher currently owns a total of 1 stock. Nishan Garabedian Christopher owns 29,552 shares of Sarepta Therapeutics Inc (SRPT) as of February 27, 2015, with a value of $4 Million.
Latest Holdings of Nishan Garabedian Christopher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2015-02-27 | 29,552 | 121.61 | 3,593,819 |
Holding Weightings of Nishan Garabedian Christopher
Nishan Garabedian Christopher Form 4 Trading Tracker
According to the SEC Form 4 filings, Nishan Garabedian Christopher has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 800 shares on February 27, 2015, which cost Nishan Garabedian Christopher around $9,456.
Insider Trading History of Nishan Garabedian Christopher
- 1
Nishan Garabedian Christopher Trading Performance
GuruFocus tracks the stock performance after each of Nishan Garabedian Christopher's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nishan Garabedian Christopher is 80.04%. GuruFocus also compares Nishan Garabedian Christopher's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nishan Garabedian Christopher within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nishan Garabedian Christopher's insider trading performs compared to the benchmark.
Performance of Nishan Garabedian Christopher
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.75 | | | | | |
| Relative Return to S&P 500(%) | 25.31 | | | | | |
Nishan Garabedian Christopher Ownership Network
Ownership Network List of Nishan Garabedian Christopher
Ownership Network Relation of Nishan Garabedian Christopher
Nishan Garabedian Christopher Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Nishan Garabedian Christopher is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Nishan Garabedian Christopher made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .
In summary, during the past 3 months, insiders sold 5,985 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net purchase of 31,053 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Nishan Garabedian Christopher Mailing Address
Above is the net worth, insider trading, and ownership report for Nishan Garabedian Christopher. You might contact Nishan Garabedian Christopher via mailing address: 333 River Street, #303, Hoboken Nj 07030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
